SF2071 (Legislative Session 94 (2025-2026))

Step therapy use protocol for insulin drugs prohibition

Related bill: HF743

AI Generated Summary

This bill, S.F. No. 2071, proposes an amendment to Minnesota Statutes to prohibit the use of step therapy protocols for prescription insulin drugs in health insurance plans.

Key Provisions of the Bill:

  • Definition of Terms:

    • "Diabetes" includes Type 1 diabetes, Type 2 diabetes, and gestational diabetes, as defined by the Centers for Disease Control and Prevention (CDC).
    • "Prescription insulin drug" follows the definition in Minnesota Statutes, section 62Q.48, subdivision 2.
    • "Step therapy protocol" follows the definition in Minnesota Statutes, section 62Q.184, subdivision 1.
  • Prohibition on Step Therapy for Insulin:

    • Health insurance plans that cover diabetes treatment cannot require patients to go through step therapy protocols for obtaining prescription insulin.
    • Step therapy protocols generally require patients to try less expensive or insurer-preferred treatments first before gaining access to other prescribed medications.

This measure aims to ensure immediate access to prescribed insulin medications for diabetes patients without requiring them to fail first on insurer-preferred alternatives.

Bill text versions

Actions

DateChamberWhereTypeNameCommittee Name
March 02, 2025HouseFloorActionIntroduction and first reading
March 02, 2025SenateFloorActionIntroduction and first reading
March 02, 2025HouseFloorActionReferred toCommerce and Consumer Protection
March 02, 2025SenateFloorActionReferred toCommerce and Consumer Protection
March 05, 2025SenateFloorActionAuthor added